Larvol Delta - HBV-A-Phase-II-Clinical-Study-of-BW20507-in-Combination-With-PEGIFN-for-the-Treatment-of-Hepatitis-B

BW-20507 - Argo Biopharma

http://clinicaltrials.gov/ct2/show/NCT07135349

Jan 16, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next